ListarMED_Articles por tema "oral glucose-lowering drugs"
Mostrando ítems 1-1 de 1
-
Comparison of baseline clinical characteristics among people with type 2 diabetes on second-line therapy previously added with dapagliflozin or another oral glucose-lowering drug: AGORA study
Elsevier (2024)Introduction: Type 2 diabetes mellitus (T2D) has acquired epidemic proportions worldwide. In recent years, new oral glucose-lowering drugs (OGLD) have emerged that improve the cardiovascular---kidney---metabolic control ...